Skip to main content

Nasdaq IPOs

Renaissance IPO Index – Notice of March 2020 Quarterly Changes

6 years 6 months ago
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD Reynolds Con
Renaissance Capital

Renaissance IPO Index – Notice of March 2020 Quarterly Changes

6 years 6 months ago
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD Reynolds Con
Renaissance Capital

Renaissance IPO Index – Notice of March 2020 Quarterly Changes

6 years 6 months ago
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD
Renaissance Capital

Renaissance IPO Index – Notice of March 2020 Quarterly Changes

6 years 6 months ago
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions: OneConnect Financial Technology PPD
Renaissance Capital

Phase 1 biotech Keros Therapeutics files for an $86 million IPO

6 years 6 months ago
Keros Therapeutics, a Phase 1 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million in
Renaissance Capital

Phase 1/2 biotech Keros Therapeutics files for an $86 million IPO

6 years 6 months ago
Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million i
Renaissance Capital

Phase 1/2 biotech Keros Therapeutics files for an $86 million IPO

6 years 6 months ago
Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 million i
Renaissance Capital

Phase 1/2 biotech Keros Therapeutics files for an $86 million IPO

6 years 6 months ago
Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 mill
Renaissance Capital

Phase 1/2 biotech Keros Therapeutics files for an $86 million IPO

6 years 6 months ago
Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.  The Lexington, MA-based company was founded in 2015 and booked $10 mill
Renaissance Capital

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

6 years 6 months ago
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Canopy Growth
Renaissance Capital

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

6 years 6 months ago
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Canopy Growth
Renaissance Capital

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

6 years 6 months ago
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Cano
Renaissance Capital

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

6 years 6 months ago
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Cano
Renaissance Capital

US IPO Week Ahead: 1 cannabis SPAC lights up a dim IPO market

6 years 6 months ago
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week. Led by former Cano
Renaissance Capital
Checked
13 minutes 40 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed